Copyright
©The Author(s) 2018.
World J Gastrointest Pharmacol Ther. Sep 5, 2018; 9(4): 31-38
Published online Sep 5, 2018. doi: 10.4292/wjgpt.v9.i4.31
Published online Sep 5, 2018. doi: 10.4292/wjgpt.v9.i4.31
Figure 1 Study design.
CRC: Colorectal cancer; BRFSS: Behavioral Risk Factor Surveillance System; FOBT: Fecal Occult Blood testing.
Figure 2 Odds ratios for fecal occult testing, sigmoidoscopy and colonoscopy.
FOTL: Fecal occult testing (same as FOBT: Fecal occult blood testing).
- Citation: Perisetti A, Khan H, George NE, Yendala R, Rafiq A, Blakely S, Rasmussen D, Villalpando N, Goyal H. Colorectal cancer screening use among insured adults: Is out-of-pocket cost a barrier to routine screening? World J Gastrointest Pharmacol Ther 2018; 9(4): 31-38
- URL: https://www.wjgnet.com/2150-5349/full/v9/i4/31.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v9.i4.31